What role does HbA1c play in allergy?

HbA1c (glycated hemoglobin) is a well-established biomarker for average blood glucose control over the past 2–3 months, primarily used for diabetes diagnosis and monitoring. There is no direct causal evidence linking HbA1c to allergies. However, emerging immunometabolic research suggests that chronically elevated blood glucose may promote low-grade inflammation and alter immune regulation, potentially influencing allergic responses. For instance, impaired glucose tolerance might enhance TH2-driven inflammation or compromise mucosal barrier function. The evidence is mostly mechanistic, based on animal models or small human studies, and remains inconclusive. Clinically, HbA1c alone cannot predict allergy risk or guide allergy management. In consumer tests like MyBody-X, HbA1c is included in metabolic health panels, not allergy assessments. Users should not interpret a normal HbA1c as an indicator of low allergy risk. For allergy evaluation, specific IgE testing, skin prick tests, and clinical history are required. The role of HbA1c in allergy is currently unclear and not supported by robust human data.